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MAPK signaling is important for T lymphocyte devel-
opment, homeostasis, and effector responses. To
better understand the role of Mekk1 (encoded by
Map3k1) in T cells, we conditionally deleted
Map3k1 in LckCre/+ Map3k1f/fmice, and these display
larger iNKT cell populations within the liver, spleen,
and bone marrow. Mekk1 signaling controls splenic
and liver iNKT cell expansion in response to glyco-
lipid antigen. LckCre/+ Map3k1f/fmice have enhanced
liver damage in response to glycolipid antigen.
Mekk1 regulates Jnk activation in iNKT cells and
binds and transfers Lys63-linked poly-ubiquitin
onto Carma1. Map3k1 is critical for the regulation of
p27Kip1 (encoded by Cdkn1b).INTRODUCTION
Mitogen-activated protein kinase (MAPK) kinase (MAP2K) ki-
nases (MAP3Ks) are important regulators of IkB kinases (IKKs)
andMAP2Ks (Dong et al., 2002; Ghosh and Karin, 2002; Kyriakis
and Avruch, 2001; Raman et al., 2007; Suddason and Gallagher,
2015). Nineteen MAP3Ks are present in mammals, though their
precise roles in regulating the immune system are not fully under-
stood (Karin and Gallagher, 2005; Suddason and Gallagher,
2015).Mek kinase 1 (Mekk1) is unique in containing both a kinase
domain and a plant homeodomain (PHD), that can bind trans-
forming growth factor (Tgf)-b-activated kinase 1 (Tak1)-binding
protein 1 (Tab1) and act as an E3 ubiquitin (Ub) ligase (Suddason
and Gallagher, 2015; Charlaftis et al., 2014). Map3k1DKD B cells
regulate Jnk and p38 signaling from tumor necrosis factor (TNF)
receptor family members (TNFRs) (Matsuzawa et al., 2008; Gal-
lagher et al., 2007; Karin and Gallagher, 2009). Analysis of
Map3k1DKD T cells demonstrated that Mekk1 is an important
regulator of T helper 2 (Th2) cytokine production by the Jnk-
dependent activation of Itch (Enzler et al., 2009; Gallagher
et al., 2006; Gao et al., 2004; Fang et al., 2002; Venuprasad
et al., 2006). Moreover, an intact Mekk1 PHD motif is required
for Itch phosphorylation following T cell receptor (TCR) signaling
(Suddason and Gallagher, 2015; Charlaftis et al., 2014), though
the means by which Mekk1 is recruited to the TCR remain toCebe clarified. Map3k1DKD CD8+ T cells display enhanced expan-
sion in response to viruses, but the mechanism remains uncer-
tain (Labuda et al., 2006). The analysis of the precise role of
Mekk1 in T cells using Map3k1DKD mice has been complicated
by both B lymphocyte defects and also the partial lethality of
Map3k1DKD mice on the C57BL/6 background (Bonnesen
et al., 2005; Gallagher et al., 2007).
T lymphocytes form a critical cellular component of the adap-
tive immune response and can be broadly subdivided into con-
ventional and unconventional subtypes (Kronenberg and Gapin,
2002; von Boehmer, 1990). Of these, natural killer T (NKT) cells
constitute a unique unconventional T cell population of the
immune system (Kronenberg and Gapin, 2007). By contrast to
conventional CD4+ and CD8+ T cells, which are reactive to major
histocompatibility complex (MHC) class I- or II-associated pep-
tides, NKT cells can recognize lipids in the context of CD1d mol-
ecules (Bendelac et al., 1995; Spada et al., 1998; Brossay et al.,
1998). NKT cells may express a skewed range of TCR variable
region genes and the natural killer (NK) cell marker NK1.1 (Sko¨ld
et al., 2000). NKT cells can be subdivided into three categories
based on their reactivity to the glycolipid a-galactosylceramide
(a-GalCer), TCR a chain diversity, and CD1d dependency.
Type I invariant NKT (iNKT) cells have invariant Va14-Ja18 TCR
a chains and react to a-GalCer in a CD1d-dependent manner.
Type II nonclassical NKT cells are unreactive to a-GalCer and
have TCR a chain diversity but are CD1d dependent. NKT-like
(or type III) cells are CD1d independent, unresponsive to
a-GalCer, and possess diverse TCR a chains (Bendelac et al.,
2007). Following TCR engagement by glycolipid presented by
CD1d, iNKT cells undergo proliferative expansion and secrete
cytokines (Kawano et al., 1997; Crowe et al., 2003; Parekh
et al., 2005; Godfrey et al., 2010). Type I iNKT cells are abundant
within the liver, where they are important regulators of inflamma-
tion and liver damage (Van Kaer et al., 2013).
Here, we investigate Map3k1 by T-cell-specific and germline
ablation in mice.Map3k1 regulates iNKT cell proliferative expan-
sion in response to glycolipid antigen. CARD-containingMAGUK
protein 1 (Carma1), a TCR-associated scaffold protein, is a
target for the Mekk1 PHD motif and provides a mechanism for
Mekk1 recruitment to the TCR (Blonska and Lin, 2009; Rinco´n
and Davis, 2007). Microarray gene profiling ofMap3k1-deficient
iNKT cells undergoing their clonal burst in response to glycolipid
antigen identified Cdkn1b as a cell-cycle gene that is aberrantly
expressed inMap3k1-deficient mice (Kiyokawa et al., 1996). Thell Reports 14, 449–457, January 26, 2016 ª 2016 The Authors. 449
Figure 1. T Cell Development and Homeostasis within LckCre/+ Map3k1f/f Mice
(A) A schematic diagram representing the construction of the Map3k1f/f allele.
(B) Thymocytes, splenocytes, bone marrow, and liver cells from WT, Map3k1DKD, and LckCre/+ Map3k1f/f mice (all on the C57BL/6 background) were isolated,
stained with anti-CD4 and anti-CD8 antibodies, and analyzed by flow cytometry as indicated. Data are representative of three independent experiments.
Numbers in the profiles indicate the percentages of the gated populations.
(C) The average percentage (±SEM) of three cell populations CD4+CD8+, CD4+CD8, and CD4CD8+ cells from LckCre/+ Map3k1f/f and WT mice from six
independent experiments was statistically analyzed (green circle, CD4+CD8+; purple square, CD4+CD8; blue triangle, CD4CD8+), where appropriate, by
two-tailed Student’s t test (*p% 0.05; **p% 0.01; ***p% 0.001).regulation of p27Kip1 by Mekk1 signaling provides a cell intrinsic
molecular explanation for the altered proliferative expansion
observed in both Map3k1DKD and LckCre/+ Map3k1f/f iNKT cells.
RESULTS
Map3k1 Regulates Conventional T Cells
Because Map3k1DKD mice have both B cell defects and partial
lethality on the C57BL/6 background, we generated LckCre/+
Map3k1f/f mice (Figures 1A, S1A, and S1B) to better understand
the roles of Map3k1 in T cells (Gallagher et al., 2007; Bonnesen450 Cell Reports 14, 449–457, January 26, 2016 ª 2016 The Authorset al., 2005). Within the thymus of LckCre/+ Map3k1f/f mice,
there is a minor development defect with significantly fewer
CD4+CD8+ double-positive thymocytes than WT but a signifi-
cantly larger than WT population of CD4+ single-positive thymo-
cytes (Figures 1B and 1C; Chang et al., 2011; Charlaftis et al.,
2014). However, the total number of thymocytes in Map3k1DKD
and LckCre/+ Map3k1f/f mice is similar to WT (Table S1; Gao
et al., 2004; Venuprasad et al., 2006; Labuda et al., 2006).
Splenic CD4+ T cells isolated from LckCre/+ Map3k1f/f mice
display an enhanced production of Il4 following TCR crosslinking
with anti-CD3 and anti-CD28 antibodies (Figure S1C), the.
Figure 2. iNKT Cell Development and Homeostasis in Map3k1DKD and LckCre/+ Map3k1f/f Mice
(A) Cell suspensions were isolated from the spleen, thymus, bone marrow, and liver from WT, Map3k1DKD, and LckCre/+ Map3k1f/f mice, stained with CD1d
tetramer and anti-CD3 antibody, and analyzed by flow cytometry as indicated. Data are representative of five independent experiments. Numbers in the profiles
indicate the percentages of the gated populations.
(B) Statistical analysis of iNKT populations (CD1d tetramer+CD3+) within the spleen, thymus, bonemarrow, and liver fromWT,Map3k1DKD, and LckCre/+ Map3k1f/f
mice. The average percentage (±SEM) of CD1d-tetramer and CD3-positive cells from five independent experiments is shown (black circle, WT; red square,
Map3k1DKD; purple triangle, LckCre/+ Map3k1f/f mice). Statistical differences were analyzed by two-tailed Student’s t test (*p% 0.05; **p% 0.01; ***p% 0.001).
(C) Statistical analysis of iNKT populations (CD1d tetramer+TCRb+) within the spleen, thymus, bone marrow, and liver from WT, Map3k1DKD, and LckCre/+
Map3k1f/f mice. The average percentage (±SEM) of CD1d-tetramer and TCRb-positive cells from five independent experiments is shown (black circle, WT;
green square, Map3k1DKD; green triangle, LckCre/+ Map3k1f/f mice). Statistical differences were analyzed by two-tailed Student’s t test (*p% 0.05; **p% 0.01;
***p% 0.001).same Itch activation-dependent Th2 phenotype observed in
Map3k1DKD CD4+ T cells (Gao et al., 2004; Venuprasad et al.,
2006). By contrast, gd T cells isolated from LckCre/+ Map3k1f/f
or WT mice are not significantly different (Figure S1D; Maki
et al., 1996). LckCre/+ Map3k1f/f mice display significantly more
CD4+ and CD8+ T cells within the spleen and liver and a signifi-
cantly larger CD8+ T cell population within the bone marrow
(Figures 1B and 1C; Chang et al., 2011; Charlaftis et al.,
2014). No significant difference was detected in T cells isolated
from the thymus, spleen, liver, or bone marrow between WT
and LckCre/+ mice (Figure S1E; data not shown).CeMap3k1 Regulates iNKT Cells
LckCre/+ Map3k1f/f mice have significantly higher numbers
of iNKT cells (CD1d tetramer+CD3+, CD1d tetramer+TCRb+, or
CD1d tetramer+NK1.1+) within the liver, spleen, and bone
marrow relative to WT or LckCre/+ mice (Figures 2A–2C, S2A,
and S2B; data not shown; Ansari et al., 2010). Map3k1DKD
mice, which display a germline deletion of theMap3k1 exons en-
coding the Mekk1 kinase domain (Gao et al., 2004), similarly dis-
played significantly higher numbers of iNKT cells (CD1d tetra-
mer+CD3+, CD1d tetramer+TCRb+, or CD1d tetramer+NK1.1+)
in the liver (Figures 2B and 2C; data not shown). However,ll Reports 14, 449–457, January 26, 2016 ª 2016 The Authors. 451
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Figure 3. Map3k1 Regulates Jnk Activation in iNKT Cells
(A) iNKT cells were isolated (four mice per experiment) and stimulated by TCR crosslinking with antibodies over a 240-min time course as indicated. Cell lysates
were made and analyzed by IB with the indicated antibodies. Arrowhead indicates phospho-p38 and asterisk a non-specific band.
(B) IPA network diagram of TCR signaling to show the presence of the Mekk1 PHD substrate Carma within this pathway.
(C) In vitro ubiquitination assays usingMekk1 PHD,Mekk1mPHD, Ube2N:Ube2V1, E1, Ub, and Carma1. Reactions were performed as indicated and analyzed by
IB as indicated. A fraction of the ubiquitination reactions was taken pre-incubation, boiled, analyzed by IB as shown, and indicated as input.
(D) HEK293 cells were transfected with the indicated constructs. To detect in vivo ubiquitination, lysates were made under denaturing conditions for IP (Gallagher
et al., 2007) and IB performed as indicated. Lysates were also made under non-denaturing conditions as a loading control and IB performed with the indicated
antibodies.
(E) iNKT cells were isolated (four mice per experiment) and stimulated by TCR crosslinking with antibodies over a 60-min time course. To detect in vivo
ubiquitination, lysates were made under denaturing conditions for IP (Gallagher et al., 2007) and IB performed as indicated. Lysates were also made under non-
denaturing conditions as a loading control and IB performed with the indicated antibodies.iNKT cell development in the thymus is normal for both
Map3k1DKD and LckCre/+ Map3k1f/f mice (Figure S2C).
Mekk1 Regulates TCR-Dependent Jnk Activation in
iNKT Cells
Map3k1DKD iNKT cells were isolated and stimulated in vitro by
TCR crosslinking with antibodies (Figure 3A; Gao et al., 2004;
Nagaleekar et al., 2011). WT iNKT cells display a transient Jnk
activation at 10 min that is significantly reduced in Map3k1DKD
iNKT cells following TCR crosslinking with antibodies (Figures
3A and S3A). Phosphorylation of c-Jun is similarly reduced in
Map3k1DKD iNKT and conventional cells following TCR cross-
linking with antibodies (data not shown), but there is no signifi-
cant defect in p38 activation (Figure S3B; Gao et al., 2004).
Because Mekk1 binds and ubiquitinates proteins by its PHD
motif, we analyzed a comprehensive Mekk1 PHD protein array452 Cell Reports 14, 449–457, January 26, 2016 ª 2016 The Authorsscreen by ingenuity pathway analysis (IPA) bioinformatics to
identify hits that are important for TCR signaling and identified
Carma1 as a possible Mekk1 PHD substrate (Figure 3B; Sudda-
son andGallagher, 2015; Charlaftis et al., 2014). TheMekk1 PHD
binds and, in association with Ub-conjugating enzyme E2N
(Ube2N), transfers Lys63-linked Ub chains onto Carma1 (Figures
3C and 3D). Mekk1 and Carma1 transiently co-purify from iNKT
cells 10min following TCR crosslinking (Figure S3C), and endog-
enous Carma1 is transiently ubiquitinated following TCR cross-
linking with antibodies (Figures 3E and S3D).
Map3k1 Regulates Splenic and Liver iNKT Cell
Expansion
To assess the role of Mekk1 signaling in iNKT cell responses
to antigen, WT, Map3k1DKD, and LckCre/+ Map3k1f/f mice were
immunized with the iNKT cell TCR agonist a-GalCer (Figures 4.
Figure 4. iNKT Cell Expansion in Map3k1-Deficient Mice
(A) WT,Map3k1DKD, and LckCre/+ Map3k1f/fmice were i.p. injected with a-GalCer for 3 days. Splenocytes were harvested at days 0 and 3, stained with anti-TCRb
antibody and CD1d tetramer, and analyzed by flow cytometry as indicated. Data are representative of three independent experiments. Numbers in the profiles
indicate the percentages of the gated populations.
(B) Statistical analysis of a-GalCer-dependent iNKT expansion at days 0, 3, and 6 inMap3k1DKDmice. The average percentage (±SEM) of PBS-57-loaded CD1d
tetramer+ TCRb + cells from five independent experiments is shown (black circle, WT; black square,Map3k1DKD mice). Differences were analyzed by two-tailed
Student’s t test (*p% 0.05; **p% 0.01; ***p% 0.001).
(C) Liver cells were harvested at days 0 and 3 from WT, Map3k1DKD, and LckCre/+ Map3k1f/f mice following i.p. immunization with a-GalCer. Liver cells were
stained with CD1d tetramer and anti-TCRb antibodies and analyzed by flow cytometry as indicated. Data are representative of three independent experiments.
Numbers in the profiles indicate the percentages of the gated populations.
(D) Representative H&E-stained liver sections were prepared from unstimulated (upper panels) and 3-day a-GalCer stimulated (lower panels) WT, Map3k1DKD,
and LckCre/+ Map3k1f/fmice (original magnification340; scale bar, 10 mM). Arrows indicate lymphocyte infiltration. Data are representative of three independent
experiments (two mice per experiment).and S4). Short-term stimulation of Map3k1DKD and LckCre/+
Map3k1f/f mice with a-GalCer lead to normal iNKT activation
and cytokine production (Figure S4A; data not shown). By
contrast, splenic iNKT cells from Map3k1DKD and LckCre/+
Map3k1f/fmice display significantly reduced long-term prolifera-
tive expansion following immunization with a-GalCer (Figures
4A, 4B, and S4B; data not shown). Conversely, liver iNKT cells
from Map3k1DKD and LckCre/+ Map3k1f/f mice showed signifi-
cantly enhanced long-term proliferative expansion following im-
munization with a-GalCer (Figures 4C, S4B, and S4C). AnalysisCeof the livers from Map3k1DKD and LckCre/+ Map3k1f/f mice re-
vealed significantly enhanced lymphocyte infiltration and liver
damage following long-term immunization with a-GalCer relative
to control mice (Figures 4D and S4D).
Mekk1Controls iNKTCell Proliferative Expansion by the
Regulation of Jnk-Dependent p27Kip1 Expression
To understand the molecular basis underpinning the aberrant
proliferative expansion of both LckCre/+ Map3k1f/f and




Figure 5. Mekk1 Signaling Controls p27Kip1 Expression to Regulate iNKT Cell Proliferation
(A) WT andMap3k1DKDmice were i.p. injected with a-GalCer for 3 days. RNAwas isolated fromWT andMap3k1DKD splenic iNKT cells, processed, and hybridized
onto Affymetrix arrays. Bioinformatics analysis was performed, and a heatmap comparing gene hits between WT andMap3k1DKD iNKT cell microarray screens
was constructed. The data are from three independent experiments (four mice per experiment).
(B) Splenic and liver iNKT cells were isolated from 3-day a-GalCer-immunized LckCre/+ Map3k1f/f, WT mice stained with anti-phospho c-Jun antibody, and flow
cytometry performed as indicated (red line, WT; blue line, LckCre/+ Map3k1f/f). Data were representative of three independent experiments. Histograms show the
phospho c-Jun present in the gated iNKT cell population.
(C) Splenic iNKT cells from 3-day a-GalCer-immunized LckCre/+ Map3k1f/f and WT mice were isolated and stained with anti-p27Kip1 antibody and flow cytometry
performed as indicated (red line, WT; blue line, LckCre/+ Map3k1f/f). Data were representative of three independent experiments. Histogram shows the p27Kip1
present in the gated iNKT cell population.
(D) iNKT cells from the spleen and liver of WT and LckCre/+ Map3k1f/f mice were isolated 3 days post-i.p. injection with a-GalCer and their RNA analyzed by real-
time PCR as indicated (gray square, WT; black square, LckCre/+ Map3k1f/f). The average relative expression (±SEM) of genes from three independent experiments
was statistically analyzed, where appropriate, by two-tailed Student’s t test (*p% 0.05; **p% 0.01; ***p% 0.001).
(E) WT,Map3k1DKD, Cdkn1b/, orMap3k1DKD/Cdkn1b/ (DKO) mice were treated with water containing BrdU and i.p. immunized with a-GalCer (day 3) or left
unstimulated (day 0). Splenocytes were extracted and analyzed as indicated. Representative results (±SEM) from three quantitated iNKT proliferation experi-
ments were statistically analyzed, where appropriate, by two-tailed Student’s t test (*p% 0.05; **p% 0.01; ***p% 0.001).
(F) WT, Cdkn1b/, Map3k1DKD, or Map3k1DKD/Cdkn1b/ (DKO) iNKT cells were isolated and incubated in [3H] thymidine containing media for 24 hr in the
presence of DMSO (control), SP600125, PD98059, SB203580, NSC697923, or SU9516. The average cpm (±SEM) from three independent experiments was
statistically analyzed, where appropriate, by two-tailed Student’s t test (*p% 0.05; **p% 0.01; ***p% 0.001).
(G) WT,Map3k1DKD, and LckCre/+ Map3k1f/fmice were immunized with a-GalCer for 3 days, splenic or liver iNKT cells isolated, and Cdkn1b ChIP performed with
anti-phospho c-Jun antibody as indicated. The average relative signal (±SEM) from three independent experiments was statistically analyzed, where appropriate,
by two-tailed Student’s t test (*p% 0.05; **p% 0.01; ***p% 0.001).patterns following the long-term immunization of Map3k1DKD
mice with a-GalCer (Figure 5A; Table S2). Bioinformatics anal-
ysis of the screened hits identified Cdkn1b (encoding p27Kip1)
as a Map3k1-dependent cell-cycle regulator (Figure S5A).
LckCre/+ Map3k1f/f mice have enhanced long-term phospho-c-
Jun in splenic iNKT cells but reduced phospho-c-Jun in liver
iNKT cells, relative to WT following immunization with a-GalCer454 Cell Reports 14, 449–457, January 26, 2016 ª 2016 The Authors(Figure 5B). Cdkn1b and p27Kip1 expression is significantly
enhanced in splenic Map3k1DKD and LckCre/+ Map3k1f/f iNKT
cells, but Cdkn1b expression is significantly reduced in liver
Map3k1DKD and LckCre/+ Map3k1f/f iNKT cells following long-
term stimulation by a-GalCer (Figures 5C and 5D; data not
shown). Similarly, other screened hits (including Rorc, Il1b,
Il1f9, and Cxcr2) identified by global gene expression analysis.
were verified by real-time PCR in splenic (Figure S5B; data not
shown) and liver tissues (Figure S5C; data not shown). Integrin
gene expression (Itgb7, Itgb21, and Itgb1) is equivalent between
WT and Map3k1DKD iNKT cells (Figure S5D). Whereas splenic
iNKT cells from Map3k1DKD and LckCre/+ Map3k1f/f mice hypo-
proliferate, splenic Cdkn1b/ iNKT cells hyperproliferate
following long-term stimulation by a-GalCer (Figure 5E). iNKT
cell proliferation in response to TCR crosslinking with antibodies
is significantly reduced by chemical inhibition of Jnk, Ube2N,
or cyclin-dependent kinases (CDKs) (Figure 5F). Splenic, in
contrast to liver, Map3k1DKD and LckCre/+ Map3k1f/f iNKT cells
display greater phosphorylation of c-Jun at the Cdkn1b pro-
moter activator protein-1 (AP-1)-binding site following long-
term stimulation by a-GalCer (Figure 5G; Khattar and Kumar,
2010).
DISCUSSION
We have shown, using LckCre/+ Map3k1f/f mice, that Mekk1 has
important roles in T cells. Thymic development is moderately
skewed in LckCre/+ Map3k1f/f mice, with reduced numbers of
CD4+CD8+ double-positive thymocytes and enhanced numbers
of CD4+ single-positive thymocytes. Our findings differ from
LckCre/+ Map3k7f/f mice that display reduced numbers of CD4+
and CD8+ single-positive thymocytes (Wan et al., 2006) and
LckCre/+ Map3k2/ Map3k3 f/f mice that display normal thymic
development (Chang et al., 2011). The CD4+ and CD8+ T cell
populations are also larger within the spleen, bone marrow,
and liver tissues of LckCre/+ Map3k1f/f mice. Map3k1DKD mice
have elevated numbers of T cells in the liver, and analysis of
the iNKT cell population revealed that these are significantly
expanded in the liver of bothMap3k1DKD and LckCre/+ Map3k1f/f
mice. Two factors complicating the analysis of T cells using
Map3k1DKD mice have been the germline kinase domain muta-
tion impacting B cells and partial embryonic lethality (Gao
et al., 2004; Gallagher et al., 2007; Bonnesen et al., 2005).
Bone marrow chimeras and in vitro assays using cells from
Map3k1DKD mice have previously demonstrated that B and
T cell Mekk1 signaling defects are intrinsic (Gao et al., 2004; Ven-
uprasad et al., 2006; Labuda et al., 2006; Gallagher et al., 2007).
As such, conditional deletion ofMap3k1 in T cells using LckCre/+
Map3k1f/f mice represents a significant refinement of the anal-
ysis of Map3k1 in T cells.
TCR signaling leads to the rapid activation of MAPK and the
phosphorylation of its downstream targets (e.g., c-Jun), and
these can then initiate T cell effector responses (Su et al.,
1994; Dong et al., 2002). More recently, E3 Ub ligase Itch was
identified as a downstream Mekk1-signaling target that is phos-
phorylated by Jnk1 to induce a conformational change within the
protein leading to Itch activation and canonical ubiquitination of
Jun transcription factors (Gallagher et al., 2006; Gao et al., 2004;
Fang et al., 2002; Venuprasad et al., 2006). As with conventional
CD4+ T cells, TCR signal transduction rapidly activates Jnk in
iNKT cells and this is significantly reduced in Map3k1-deficent
iNKT cells (Gao et al., 2004). Mekk1 transiently binds and ubiqui-
tinates Carma1, a scaffold known to regulate Jnk activation,
following TCR engagement, and this provides a mechanism of
recruitment for Mekk1 to the TCR that differs from TNFRs orCeTgf-b receptors (Suddason and Gallagher, 2015; Charlaftis
et al., 2014; Gaide et al., 2002).
Our work identifies a role for Map3k1 in the regulation of the
iNKT cell proliferative expansion in response to glycolipid anti-
gen. In order to identify the mechanism underpinning Map3k1-
dependent iNKT cell expansion, we analyzed their global gene
expression profile to identify Cdkn1b as a regulated target. The
modulation of p27Kip1 expression in T cells by Mekk1 signaling
represents a molecular mechanism that regulates T cell prolif-
eration. We have identified increased iNKT cell infiltration into
the liver and a higher degree of liver damage in Map3k1DKD
and LckCre/+ Map3k1f/f mice. The aberrant iNKT cell expansion
within the spleen and liver of Map3k1-deficient mice can be
explained by altered c-Jun-dependent Cdkn1b expression.
Our results reinforce the importance of Mekk1 signaling in
T cells.
EXPERIMENTAL PROCEDURES
Gene Targeting of Map3k1
Map3k1 was targeted by insertion of a FRT site followed by a LacZ sequence
and a loxP site into chromosome 13 upstreamof the exons of theMap3k1 gene
(to generate theMap3k1f allele; Skarnes et al., 2011). The first loxP site was fol-
lowed by neo under the control of the human B-actin promoter, SV40 poly-A, a
second FRT site, and a second loxP site. A third loxP site was inserted down-
stream of the Map3k1 exons. Map3k1+/f ESCs (C57BL/6) were generated by
standard procedures (Gossler et al., 1986) and genotyped by Southern blotting
or genomic PCR (Ledermann, 2000; Gao et al., 2004; Charlaftis et al., 2014).
Four independently generatedMap3k+/f ESC clones were injected into blasto-
cysts, and the resulting transgenics were genotyped by PCR (Gao et al., 2004;
Charlaftis et al., 2014). Genomic PCR was carried out on mice biopsies using
primers to detect theMap3k1-specific WT allele, the shorter mutant allele, and
the recombinant allele (50 to 30 primers: TCGTGGTATCGTTATGCGCC;
AATAGGCCACACGTTGACTGG; and CAACCCACGAAAGGAGGTTC; Char-
laftis et al., 2014).Map3k1+/fmice were crossed with ACTFLPemice (Jackson
Laboratory) to initiate recombination at the FRT sites, deleting the lacZ and neo
and resulting in offspring that contain a Map3k1f/f allele.
Cell Line and Cell Culture Conditions
HEK293 cells were maintained in DMEM (22320; Invitrogen) supplemented
with 10% FBS (SH3007003; Thermo Scientific) and antibiotics in a humidified
atmosphere at 37C.Cells were passaged every 2 or 3 dayswhen approaching
full confluence (Charlaftis et al., 2014).
Transfection
HEK293 cells were plated in 6-well plates at a density of 13 106 cells per well.
The following day, cells were transfectedwith Lipofectamine 2000 (11668-019;
Invitrogen) or Jet Prime (114-07; Polyplus) transfection reagents according to
the manufacturer’s instructions. Cells were collected and lysed 48 hr later.
Tissue Preparation
Spleen and perfused liver tissues weremashed through a 70-mmand a 100-mm
strainer, respectively, and resuspended in RPMI 1640 medium (Invitrogen)
supplemented with 10% FBS (ThermoScientific). Following low-speed centri-
fugation, the splenic pellet was treated with red blood cell (RBC) lysis buffer
(Sigma), washed, and resuspended in medium. The liver cell pellet was resus-
pended in 38% Percoll (GE Healthcare) and then centrifuged at 500 g for
20 min at room temperature. Cell pellets were treated with RBC lysis buffer,
washed, and resuspended in medium.
Isolation of iNKT Cells
Mouse iNKT cells isolation from spleen or liver tissues was performed
using PE-conjugated and a-GalCer-loaded CD1d tetramer (Nagaleekar et al.,
2011). Tetrameric CD1d:a-GalCer cell complexes were purified using anti-PEll Reports 14, 449–457, January 26, 2016 ª 2016 The Authors. 455
MicroBeads (Miltenyi Biotec). Residual B cells were depleted prior to iNKT cell
enrichment using a CD45R (B220) MicroBead kit (Miltenyi Biotec), and the final
iNKT cell purity obtained was greater than 95%.
Flow Cytometry
Cell staining with CD1d tetramer was followed by intracellular staining per-
formed using a Fix/Perm kit (BD PharMingen). For intracellular staining, the
cells were incubated with 50 mg/ml PMA (Sigma-Aldrich), 1 mM ionomycin
(Sigma-Aldrich), and 10 mg/ml brefeldin A (Sigma-Aldrich) for 2 hr before pro-
cessing. For 5-bromo-2-deoxyuridine (BrdU) labeling, mice were fed with
BrdU (0.8 mg/ml) in drinking water supplemented with 5% (weight/volume)
glucose 1 day prior to a-GalCer (2 mg) i.p. injection. Mice were treated with
BrdU in drinking water for 3 days to study proliferation. Cells were surface
stained, and BrdU staining was performed according to the manufacturer
protocol (BD PharMingen BrdU Flow Kit). Cells were analyzed on a Cyan
ADP (DakoCytomation) flow cytometer and further analyzed on a workstation
using FlowJo software (TreeStar).
Immunoblotting, Immunoprecipitation, Real-Time PCR, and
Chromatin Immunoprecipitation
iNKT cells were isolated by magnetic selection using MACS LS columns ac-
cording to the manufacturers protocols (Miltenyi Biotech). Immunoblotting
(IB) and immunoprecipitation (IP) were carried out as previously described
(Gao et al., 2004). iNKT cell RNA was prepared with the RNeasy kit (QIAGEN),
and total RNA (500 mg) was converted to cDNA using the High Capacity cDNA
RT-Kit (Applied Biosystems). Real-time PCR was performed in triplicate with
the appropriate gene primers (Invitrogen; Table S3) using SYBR Green
(Applied Biosystems) and an ABI Prism 7700 Sequence Detector (Applied
Biosystems). b-actin was used for normalization of results. Chromatin IP
(ChIP) was performed using an EpiTect ChIP qPCR primer assay for mouse
Cdkn1b kit (QIAGEN) according to the manufacturer instructions.
Ubiquitination Assays
Carma1 cDNA was overexpressed in HEK293 cells and IP performed with
anti-FLAG antibody, washed extensively, and protein eluted. Subsequently,
Carma1 was incubated for 1 hr at 37C with the ubiquitination assay enzymes
E1 (100 nM), Ube2N:Ub-conjugating enzyme E2 variant 1 (Ube2V1; 0.36 mM),
Ub, and ATP, with or without WT Mekk1 PHD (100 ng) or Mekk1 mutant PHD
(mPHD; 100 ng; Charlaftis et al., 2014). All ubiquitination assay reagents were
from Boston Biochem.
Microarray and Bioinformatics Analysis
Total RNA from iNKT cells was reverse transcribed into biotinylated cRNA
with an RNA amplification kit according to the manufacturer’s instructions
(Ambion). RNA quality was verified using a 2100 Bioanalyzer (Agilent Tech-
nologies). Samples were hybridized to Mouse Gene 1.0 ST arrays (Affymetrix;
Charlaftis et al., 2014). Partek software was used according to the vendor
protocols for data analysis, quality control, and for creating gene lists and
scatterplots. GeneSpringX software was used according to the vendor pro-
tocols to generate heatmaps. Probes with a fold change of less than two
were discarded. Probes were quantile normalized among all microarray
data. Gene lists were uploaded into the IPA program (Ingenuity Systems)
to generate relevant signaling networks and gene wheels according to the
vendor instructions.
Liver Damage Assay
Mice were injected i.v. with 2 mg KRN7000. After 3 days, the livers were har-
vested, fixed in 4% paraformaldehyde, processed, and paraffin embedded.
H&E staining was carried out on liver sections (4 mm). Slides were analyzed
using an Olympus light microscope, and pictures were taken using Image
Pro-Software at 403 magnification.
Statistical Analysis
Data were expressed as SEM. Statistical significance was determined by
two-tailed Student’s t test. All analyses were performed using GraphPad Prism
5 software (GraphPad).456 Cell Reports 14, 449–457, January 26, 2016 ª 2016 The AuthorsACCESSION NUMBERS
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